Default: Vaccine

ISSN: 0264-410X

Journal Home

Journal Guideline

Vaccine Q1 Unclaimed

Elsevier BV Netherlands
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Vaccine is a journal indexed in SJR in Infectious Diseases and Molecular Medicine with an H index of 184. It has a price of 2395 €. It has an SJR impact factor of 1,585 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,585.

Vaccine focuses its scope in these topics and keywords: vaccine, influenza, vaccination, virus, recombinant, vaccines, immunization, protein, responses, immunogenicity, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Metrics

Vaccine

1,585

SJR Impact factor

184

H Index

1148

Total Docs (Last Year)

3184

Total Docs (3 years)

42289

Total Refs

10913

Total Cites (3 years)

2957

Citable Docs (3 years)

3,27

Cites/Doc (2 years)

36,84

Ref/Doc

Aims and Scope


vaccine, influenza, vaccination, virus, recombinant, vaccines, immunization, protein, responses, immunogenicity, live, response, immune, hn, study, safety, inactivated, hiv, infection, oral, randomized, hepatitis,



Best articles by citations

Alkyl-polyacrylate esters are strong mucosal adjuvants

View more

The influence of host factors and immunogenetics on lymphocyte responses to HepageneS vaccination

View more

A look at new models to support vaccine research and development

View more

Teenagers' lifestyle and the risk of exposure to hepatitis B virus

View more

Predictive value of pre-clinical work for vaccine safety assessment

View more

Rational approaches to reduce adverse reactions in man to vaccines containing tetanus and diphtheria toxoids*1

View more

Maternal immunization: the influence of liability issues on vaccine development

View more

Analysis of factors influencing vaccine uptake from various perspectives

View more

Analysis of factors influencing vaccine uptake: perspective from Spain

View more

Analysis of factors influencing vaccine uptake: perspectives from Belgium

View more

Regulating vaccines involving new technologies to ensure safety and timely licensure - the challenge

View more

Pneumococcal infections in New Zealand

View more
SHOW MORE ARTICLES

The antigenic and immunogenic properties of synthetic peptide immunocontraceptive vaccine candidates based on gamete antigens

View more

Efficacy of Vi polysaccharide vaccine against strains of Salmonella typhi: reply

View more

Induction of mucosal antibody responses by microsphere-encapsulated formalin-inactivated simian immunodeficiency virus in a male urethral challenge model

View more

Induction of mucosal immunity with a replication-defective adenoviral recombinant

View more

DNA pulsed macrophage-mediated cDNA expression library immunization in vaccine development

View more

The medical scientist working with the media for the public good

View more

How to improve communication on vaccine issues at the national level?

View more

How to improve communication on vaccine safety at international level?

View more

Statistical assessment of the association between vaccination and rare adverse events post-licensure

View more

Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose

View more

Pre-clinical and clinical investigation of the safety of a novel adjuvant for intranasal immunization

View more

Perception of risk of vaccine adverse events: a historical perspective

View more

Comments

No comments ... Be the first to comment!

FAQS